Iveco Group N.V. (IVCGF)
USD 9.91
(0.0%)
USD 9.91
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.33 Billion | 1.4 Billion | 539 Million | 559 Million | 709 Million | 355 Million |
| Net Income | 234 Million | 147 Million | 52 Million | -408 Million | 84 Million | 166 Million |
| Depreciation & Amortization | 599 Million | 560 Million | 567 Million | 580 Million | 541 Million | 465 Million |
| Deferred income taxes | 30 Million | -11 Million | 43 Million | -158 Million | -11 Million | 36 Million |
| Stock-based compensation | 19 Million | 17 Million | 18 Million | 8 Million | 4 Million | 8 Million |
| Change in working capital | 525 Million | 507 Million | -343 Million | 187 Million | 121 Million | -209 Million |
| Other non-cash items | -22 Million | 1.02 Billion | 1.69 Billion | 1.39 Billion | 950 Million | 1.07 Billion |
| Investing Cash Flow | -2.22 Billion | -1.34 Billion | -45 Million | -90 Million | -754 Million | -213 Million |
| Investments in PPE | -970 Million | -777 Million | -564 Million | -401 Million | -492 Million | -437 Million |
| Acquisitions | -21 Million | 75 Million | 14 Million | 3 Million | 21 Million | 1 Million |
| Investment purchases | -40 Million | -30 Million | -44 Million | -222 Million | -96 Million | - |
| Sales/Maturities of investments | - | 29 Million | 85 Million | - | - | - |
| Other Investing Activities | -1.23 Billion | -637 Million | 464 Million | 530 Million | -187 Million | 223 Million |
| Financing Cash Flow | 1.48 Billion | 1.34 Billion | -88 Million | -407 Million | -29 Million | -55 Million |
| Debt repayment | -1.52 Billion | -442 Million | -63 Million | -47 Million | -216 Million | -53 Million |
| Dividends payments | - | -1 Million | - | - | -1 Million | -1 Million |
| Common Stock Repurchased | -55 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 17 Million | 904 Million | -151 Million | -360 Million | 188 Million | -107 Million |
| Accounts receivables | -90 Million | -35 Million | 115 Million | -107 Million | 40 Million | -43 Million |
| Accounts payables | 368 Million | 555 Million | 42 Million | 102 Million | 150 Million | -8 Million |
| Inventory | -97 Million | -219 Million | -496 Million | 133 Million | -84 Million | -198 Million |
| Other working capital | 712 Million | 206 Million | -4 Million | 59 Million | 15 Million | 40 Million |
| Cash at beginning of period | 2.28 Billion | 897 Million | 463 Million | 417 Million | 496 Million | 522.39 Million |
| Cash at end of period | 2.69 Billion | 2.28 Billion | 897 Million | 463 Million | 417 Million | 496 Million |
| Capital Expenditure | -970 Million | -777 Million | -564 Million | -401 Million | -492 Million | -437 Million |
| Effect of forex changes on cash | -191 Million | -21 Million | 28 Million | -16 Million | -5 Million | -47 Million |
| Net cash flow / Change in cash | 410 Million | 1.39 Billion | 434 Million | 46 Million | -79 Million | -26.39 Million |
| Free Cash Flow | 366 Million | 630 Million | -25 Million | 158 Million | 217 Million | -82 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 172 Million | 27 Million | -25 Million | 218 Million | 86 Million | 151 Million |
| Depreciation & Amortization | 157 Million | 152 Million | 166 Million | 599 Million | 148 Million | 147 Million |
| Deferred income taxes | 13 Million | 4 Million | 35 Million | 30 Million | -13 Million | 5 Million |
| Stock-based compensation | 1 Million | 6 Million | 19 Million | 19 Million | - | 5 Million |
| Change in working capital | -143 Million | -590 Million | 1.37 Billion | 289 Million | -573 Million | 78 Million |
| Other non-cash items | -38 Million | 352 Million | 419 Million | 1.21 Billion | 445 Million | 315 Million |
| Investing Cash Flow | -76 Million | 464 Million | -1.55 Billion | -2.22 Billion | -113 Million | -816 Million |
| Investments in PPE | -211 Million | -126 Million | -429 Million | -970 Million | -212 Million | -182 Million |
| Acquisitions | -2 Million | 2 Million | 2 Million | 17 Million | 14 Million | -11 Million |
| Investment purchases | 18 Million | -18 Million | -19 Million | -40 Million | - | -11 Million |
| Sales/Maturities of investments | 37 Million | - | -12 Million | - | 1 Million | 6 Million |
| Other Investing Activities | 135 Million | 606 Million | -1.09 Billion | -1.23 Billion | 84 Million | -629 Million |
| Financing Cash Flow | -419 Million | -186 Million | 1.22 Billion | 1.48 Billion | 96 Million | 290 Million |
| Debt repayment | -185 Million | - | -751 Million | -827 Million | -37 Million | -16 Million |
| Dividends payments | -60 Million | -31 Million | - | - | - | - |
| Common Stock Repurchased | -2 Million | -28 Million | -16 Million | -55 Million | -18 Million | -21 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -172 Million | -127 Million | 567 Million | 717 Million | 77 Million | 174 Million |
| Accounts receivables | - | - | -90 Million | -90 Million | - | - |
| Accounts payables | - | - | 291 Million | 368 Million | - | - |
| Inventory | - | - | -97 Million | -97 Million | - | - |
| Other working capital | -143 Million | -486 Million | 1.27 Billion | 108 Million | -420 Million | 109 Million |
| Cash at beginning of period | 2.61 Billion | 2.69 Billion | 1.45 Billion | 2.28 Billion | 1.69 Billion | 1.85 Billion |
| Cash at end of period | 2.25 Billion | 2.61 Billion | 2.69 Billion | 2.69 Billion | 1.45 Billion | 1.69 Billion |
| Capital Expenditure | -211 Million | -126 Million | -429 Million | -970 Million | -212 Million | -182 Million |
| Effect of forex changes on cash | -12 Million | -5 Million | -66 Million | -191 Million | -28 Million | -54 Million |
| Net cash flow / Change in cash | -359 Million | -87 Million | 1.24 Billion | 410 Million | -238 Million | -167 Million |
| Free Cash Flow | -63 Million | -485 Million | 1.21 Billion | 366 Million | -415 Million | 220 Million |
DALBHARAT
VAXX
1851
4588
MGX
9405